Intraperitoneal antibiotics are used to treat Pseudomonas aeruginosa peritonitis, a serious complication of continuous ambulatory peritoneal dialysis. However, P. aeruginosa killing is often inefficient despite low MBCs. Broth dilution MIC/MBC and time kill curves of tobramycin, amikacin, netilmicin, azlocillin, piperacillin, ceftazidime, cefsulodin, and ciprofloxacin were determined in peritoneal dialysis fluid (PDF), buffered PDF, fluid recovered from patients on continuous ambulatory peritoneal dialysis (RPF), and cation-supplemented Mueller-Hinton broth. MBCs of all antibiotics were 8 to 16 times greater in PDF and RPF than in Mueller-Hinton broth or buffered PDF. Use of the time kill curve technique and Muelier-Hinton broth showed that aminoglycosides killed .99.9% of P. aeruginosa at 1 h, ciprofloxacin killed -99.9% at 2 h, and
1-lactams killed .99.9% at 6 h. In contrast, killing was not demonstrated in PDF by any drug at 6 h and by aminoglycosides only at 24 h. Bactericidal activity was optimal in RPF for ciprofloxacin at 1 h and for aminoglycosides at 2 h; bactericidal activity was not demonstrated in RPF with any 13-lactam (no kill by penicillins; <99% kill by cephalosporins). Slow bacterial growth, increased protein binding, and glucose concentrations and other inhibitors may interfere with P-lactam activity in RPF. These considerations and reported clinical failures and toxicity of aminoglycoside therapy warrant further study of quinolones and drug combinations in P. aeruginosa peritonitis.
Continuous ambulatory peritoneal dialysis (CAPD), used in the treatment of patients with end-stage renal failure, is often complicated by peritonitis (4, 5, 7, 10) , which occurs once per 11.3 to 13.1 patient-months (3, 9) . The causative organisms are mainly gram-positive cocci (Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus spp.), accounting for 50 to 65% of all episodes, and aerobic gram-negative bacilli (Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp.), accounting for 15 to 30% of the cases (5, 6) . In one study, P. aeruginosa was the most frequently encountered gram-negative organism, accounting for 38.5% of gram-negative peritonitis and 9.6% of all cases (6) . Peritonitis caused by P. aeruginosa has been associated with abscess formation, peritoneal fibrosis, and a high failure rate of antibiotic therapy, often necessitating removal of the intraperitoneal (i.p.) catheter (4, 6) .
Many authors recommend i.p. administration of aminoglycosides for the treatment of gram-negative peritonitis (3, 5, 10, 12) . The i.p. doses commonly used are generally chosen to achieve concentrations similar to their usual peak concentrations in serum (i.e., 6 to 8 ,ug of gentamicin or tobramycin per ml of dialysate) (3) (4) (5) (6) 10) . Unfortunately, such regimens have been associated with sustained, potentially toxic concentrations of aminoglycosides in serum (4, 5) and in one clinical study failed to eradicate P. aeruginosa despite the antibacterial activity predicted by in vitro testing (6) .
Few studies have addressed the activity of antibiotics against P. aeruginosa in peritoneal dialysis fluid (PDF) (1) The present study was designed to evaluate the in vitro activity of various antibiotics active against P. aeruginosa, including several investigational compounds, in PDF, buffered PDF ( t pH PDF), and from RPF. A comparison of several features of PDF and RPF is outlined in Table 2 . Of note are the pH differences, high glucose concentrations, and the protein content in RPF.
The rate of antibacterial activity of different antibiotics against P. aeruginosa strains in various fluids is illustrated in Fig. 1 through 6 . The time kill curves obtained with amikacin and netilmicin were similar to those of tobramycin, whereas those of azlocillin were similar to those of piperacillin.
The data illustrated in Fig. 2 
DISCUSSION
The lack of bactericidal activity of f-lactams against P. aeruginosa in commercial PDF and RPF compared with standard broth can be attributed to several factors.
Slow bacterial growth, and hence reduced cell wall synthesis, has been associated in vitro with decreased bactericidal activity of P-lactams and other cell-wall-active drugs (8) . This is supported by our data, which showed that maximal rates of bactericidal activity in the control broth (2 to 6 h after inoculation) correlated with the time of maximal rate of bacterial growth. Similarly, a decreased growth rate of P. aeruginosa in the three different types of fluids tested, i.e., PDF, T pH PDF, and RPF, compared with MHB correlated with decreased bactericidal activity of P-lactams in these fluids.
Penicillin activity is adversely affected by low pH (13). This fact is reflected by the higher MBCs in the acidic PDF. However, buffering PDF to a pH of 7.4 had only a minimal effect on the rate of bactericidal activity of the P-lactams as measured by the kinetic studies. Factors such as rotational incubation, aeration, or volume differences may have contributed to this discrepancy. In addition, the pH of the RPF There is evidence of an adverse effect of high glucose concentration on penicillin activity (14) . The glucose concentrations in PDF, t pH PDF, and RPF were well above the physiological serum range (Table 2 ) and therefore could have contributed to the inhibition of P-lactam activity.
Decreased bactericidal activity of P-lactams in urine with increased osmolarity has been reported (15) . Although this factor may have played a role in inhibiting antibiotic activity in PDF and T pH PDF (osmolarity, 346 mosM/liter), it could not have in iso-osmolar RPF.
The peritoneal effluent derived from patients undergoing CAPD contains a high concentration of urea and other waste products. Although these components were not measured in the present study, they may have had an effect on bacterial growth and ,B-lactam activity. This requires further investigation.
The activity of the aminoglycosides and the carboxyquin- olone derivative, ciprofloxacin, were decreased in PDF, most probably because of the low pH of this solution (2, 11) . This is further supported by the marked improvement in activity of these compounds in buffered PDF and in RPF (pH, 7.4 to 7.54).
The favorable bactericidal activity of aminoglycosides in RPF as measured by the time kill curve technique is of interest in view of the high MBCs of these drugs in the same fluid as measured by the tube broth dilution method. Factors that may have contributed to the enhanced aminoglycoside activity in the kinetic studies include constant mixing of drug and organisms and potentially improved oxygenation in the shaking flasks during kinetic studies, as opposed to the stationary tubes when MBCs were tested.
The present in vitro study implies that the i.p. administration of anti-pseudomonas P-lactams in dialysis fluid for the treatment of CAPD-related P. aeruginosa peritonitis might be inadequate. The use of aminoglycosides in this setting, 
